Mifid equivalence delay threatens Hong Kong dual-listed stocks

HSBC, Stan Chart and Prudential shares could face trading disruption in 2018

Not on track: "If HKEX doesn't get equivalence, participants are in a tight spot" – PwC's Ramakrishnan

Delays with European Commission equivalence decisions for third-country regulatory regimes are raising fears that the advent of the second Markets in Financial Instruments Directive (Mifid II) and associated regulation (Mifir) in January 2018 could disrupt trading in European stocks dual-listed in Hong Kong – a group that includes financial heavyweights HSBC, Standard Chartered and UK insurer Prudential.

Under Mifid II, any equities listed in Europe can only be traded on a third-country venue

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact [email protected] or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to copy this content. Please contact [email protected] to find out more.

To continue reading...

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here: